References
- Reinberg A., Halberg F. Circadian chronopharmacology. A Rev Pharmacol 1971; 11: 455–492
- Smolensky M. H., Tatar S. E., Bergman S. A., Losman J. G., Barnard C. N., Daco C. C., Kraft I. A. Circadian rhythmic aspects of human cardiovascular function: a review by chronobiologic statistical methods. Chronobiologia 1976; 3: 338–371
- Halberg F., Stephen S. A. Susceptibility to ouabain and physiologic circadian periodicity. Proc Minn Acad Sci 1959; 27: 139–143
- Lutsch E. F., Morris R. W. Circadian periodicity to lidocaine hydrochloride. Science 1967; 156: 100–102
- Sensi S., Capani F., D'llario F., DiTommaso M., Debenedetto F., Delle Vechia R., Sborgia F. Circadian rhythm of the effect of digitalis on ventricular function in healthy man. Proceedings of the XII Int. Conf., F. Halberg, et al. Pavia Publishing house, II Ponte, 1981; 121–124
- Holter N. J. New Method for heart studies: continuous electrocardiography of active subject over long periods is now practical. Science 1961; 134: 1214
- Lemmer B., Lang P. H. Circadian stage dependency in antagonist binding of [3H]-dihydroalprenolol to rat heart ventricular membranes. A Rev Chronopharmacol, A. Reinberg, et al. Pergamon Press, Oxford
- Lemmer B. Pharmacokinetics of β-adrenoceptors blocking drugs of different polarity (propranolol, metoprolol, atenolol) in plasma and various organs of the light-dark synchronised rat. Naunyn Schmiedebergs Arch Pharmacol 1981; 316: R-60
- Alvisi V., Degliuberti E., Longhini C, Ruina M., Pavani F., Tralli M., Bagni B., Portallupi F., Fersini C. Evidence for circadian rhythm of digoxin bioavailability. Chronopharmacology and Chronothera-peutics, C. A. Walker, et al. Florida A and M, University Foundation. 1981; 141–144
- Carosella L., DiNardo P., Bernabei R., Cocchi A., Carbonin P. Chronopharmacokinetics of digitalis. Circadian variations of B-methyldigoxine serum levels after oral administration. Chronopharmacology and Chronotherapeutics, C. A. Walker, et al. Florida A. and M, University Foundation. 1981; 141–144
- Garretson L. K., Jusko W. J. Diphenylhyldantoin elimination kinetics in overdosed children. Clin Pharmacol Ther 1975; 17: 481–491
- Furlanut M., Benetello P., Mayellaro F., Dallabarba G., Billi M. Possible circadian rhythm of diphenylhydantoin metabolism in epileptic patients. Riv Farmacol Ter 1978; 9: 259–265
- Bruguerolle B., Jadot G., Valli M., Bouyard L., Bouyard P. Etude chronocinetique de la lidocaine chez le rat. J Pharmacol 1982; 13: 65–76
- Bruguerolle B. Chronopharmacokinetics of procainamide and A'-acetylprocainamide in the rat. Comm. 9th Intern. Pharmacol., London, 1984, Abstract No. 488 P
- Gomeni C., Gomeni R. IGPHARM: interactive graphic package for pharmacokinetics analysis. Computer Biomed Res 1978; 11: 345–361
- Ranney R. E., Dean R. R., Karim A., Radzialowski F. M. Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent. Arch Int Pharmacodyn Ther 1971; 191: 162–188
- Kock-Weser J. Drug therapy. Disopyramide. New Engl J Med 1979; 300: 957–962
- Heel R. C., Brogden R. N., Speight T. M., Avery G. S. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs 1978; 15: 331–368
- Karim A., Cook C, Campion J., Doherty M. Disopyramide phosphate: tissue uptake and relationship between drug concentration in the plasma and myocardium of rats. Arch Int. Pharmacodyn Ther 1977; 228: 222–236
- Karim A., Nissen C., Azarnoff D. Clinical pharmacokinetics of disopyramide. J Pharmacokinet Biopharm 1982; 10: 465–494
- Hinderling P. H., Bres J., Garret E. R. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite. J. Pharm Sci 1974; 63: 1684–1690
- Aitio M. L. Plasma concentrations and protein binding of disopyramide and mono-A'-dealkyldisopyramide during chronic oral disopyramide therapy. Br J Clin Pharmacol 1981; 11: 369–376
- Karim A., Ranney R. E., Kraychy S. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate. J Pharm Sci 1972; 61: 888–893
- Bruguerolle B. Orcadian changes in pharmacokinetics. Thérapie 1983; 38: 223–235
- Bruguerolle B., Valli M., Bouyard L., Jadot G., Bouyard P. Circadian effect on carbamazepine kinetics in rat. Eur J Drug Metab Pharmacokinet 1981; 6: 189–193
- Lew G. M. Circadian rhythms in blood pressure and norepinephrine in genetically hypertensive and normotensive rats. Gen Pharmacol 1976; 7: 35–40
- Patterson E., Stetson P., Lucchesi B. R. Disopyramide plasma and myocardial tissue concentrations as they relate to antiarryhtmic activity. J. Cardiovasc Pharmacol 1979; 1: 541–550